Israeli company set to become world's first country to launch clinical trials of ORAL Covid vaccine
Israeli company is set to become first in the world to launch clinical trials of an ORAL COVID-19 vaccine
- Oravax Medical, a subsidiary of Jerusalem-based Oramed Pharmaceuticals, is developing an oral COVID-19 vaccine
- The oral vaccine targets three proteins on the virus rather then the single spike protein that the Pfizer-BioNTech and Moderna vaccines target
- Researchers say it is faster, cheaper and easier to manufacture than injectable and can be distributed to poorer countries
- The team will first test if one or two pills are more effective and then compare the vaccine to a placebo
An Israeli company is set to become the first in the world to begin clinical trials of an oral COVID-19 vaccine.
Oravax Medical, a subsidiary of Jerusalem-based Oramed Pharmaceuticals, has received a green light to begin the study from the Institutional Review Board at Sourasky Medical Center in Tel Aviv.
The team is now waiting for approval from the Health Ministry, which is expected within a few weeks.
Oramed CEO Nadav Kidron told The Jerusalem Post that an oral vaccine would …
More on: www.dailymail.co.uk